Integral Diagnostics Director Discloses On-Market Share Purchase
IDX: $1.76 -0.56% · MC: $622M
Integral Diagnostics director Kevin Shaw disclosed an on-market purchase of shares through an account held jointly with Dr Jane Jie Li; the notice reports no change to the disclosed holdings before and after the transaction. The announcement gives the transaction date as November 30, 2026, which is after its October 30 publication date.

Comments